Dectrekumab - CAS 1528523-94-5

Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13 that reduces the number of eosinophils in the epithelium of patients with eosinophilic esophagitis (EoE), ameliorates transcriptional dysregulation associated with esophageal disease, and is indicated for use in the study of immune system disorders.

IL Receptor, Interleukin

Immunology/Inflammation

1528424

0.971

-20°C

Ice Packs

Inhibitory Antibodies